アルツハイマー病のAbeta16-22ペプチドをベータシートにインシリコ組み立て
Sébastien Santini1, Normand Mousseau, Philippe Derreumaux
1Contribution from the Information Génomique et Structurale, UPR 2589 CNRS, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex 20, France.
Journal of the American Chemical Society
|September 16, 2004
まとめ
研究者らは,アルツハイマー病のAβ (16-22) ペプチドの折り畳みをシミュレートし,オーダーされた繊維構造にはより大きな集合体が必要であることを明らかにしました. 折り畳みプロセスは,ダイマー形成とモノマー添加を伴うもので,無秩序と秩序のベータ鎖の配列をバランスするメカニズムを通して進行します.
科学分野:
- バイオケミストリー バイオケミストリー
- コンピュータ生物学 コンピュータ生物学
- 神経科学は神経科学である.
背景:
- アミロイド形成ペプチドの溶解性オリゴマーは,細胞毒性に関与しています.
- アルツハイマー病は,アミロイドベータペプチドの集積と関連しています.
研究 の 目的:
- アルツハイマー病のAβペプチドの折り畳みプロセスをシミュレートするために.
- 折りたたみ中のこれらのペプチドの構造的移行と均衡状態を調査する.
主な方法:
- 分子シミュレーションのアクティベーション・リラクゼーション技術を活用した.
- ペプチドの折り畳みを研究するために一般的なエネルギーモデルを使用しました.
- 最低エネルギー構造とその繊維構造からの偏差を分析した.
主要な成果:
- 予測された最も低いエネルギー構造は,繊維の形状 (RMSDの1年以内) と密接に一致しました.
- 反並列のベータシート構造は,より順番が少ない構造 (レジスタ外および混合ベータシート) との均衡状態であることが判明しました.
- ペプチドの折り畳みは,ダイマー形成と,その後のモノマー添加を経由して進みます.
結論:
- 完全にオーダーされた繊維構造を達成するには,より大きな集合体の形成が必要になります.
- 折り畳みメカニズムは,無秩序と秩序のベータ鎖のアライメントの間の移行を含みます.
- これらの折り畳みダイナミクスを理解することは,アルツハイマー病の研究にとって極めて重要です.
関連する概念動画
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...